Parasites: Do trypanosome turncoats wait before they commit?

  1. Cher-Pheng Ooi
  2. Gloria Rudenko  Is a corresponding author
  1. Imperial College London, United Kingdom

African trypanosomes cause sleeping sickness in humans, which is potentially lethal if left untreated. However, in order to spread to new hosts, these deadly parasites must be transmitted by tsetse flies, and this need to alternate between life in the mammal and life in the insect has made their biology unique. This includes the ability to undergo a metamorphosis from a form that rapidly proliferates within the bloodstream to a non-proliferative form that is prepared for life in the fly (Figure 1A; MacGregor et al., 2011, 2012). Normally, this change takes place when the concentration of the proliferative form of the parasite in the bloodstream reaches a certain density.

Trypanosomes must radically change in order to survive in both mammals and tsetse flies.

(A) Trypanosomes proliferating in the mammalian bloodstream change into a non-proliferative form that is capable of transferring into a tsetse fly. All bloodstream trypanosomes have a dense surface VSG coat. (B) Trypanosomes express VSG proteins from a VSG expression site at a chromosome end (black triangles). The VSG expression sites include expression site associated genes (ESAGs; yellow boxes) as well as the telomeric VSG genes (red box). In the top panel, VSG1 is being expressed, with transcription (green arrow) proceeding from a promoter (white flag). Batram et al. found that inducing parasites to express a different VSG—labelled here as VSG 2 (blue box)—from another genomic location (black flag) results in a repressive gradient silencing the active expression site (red arrow). This not only silences VSG 1, but also reduces the expression of ESAGs near VSG 1.

In the mammal, trypanosomes are covered with a protective coat made of variant surface glycoprotein (VSG). In order to avoid detection by host antibodies, trypanosomes repeatedly switch to new VSG coats (Horn and McCulloch, 2010). Now, in eLife, Markus Engstler and colleagues from the University of Würzburg—including Christopher Batram as first author—argue that the process of switching the VSG coat could play a central role in both helping the trypanosome to avoid the mammalian immune system and helping it to escape from the mammal into the insect (Batram et al., 2014).

In the bloodstream, trypanosomes express only one VSG coat at a time out of a repertoire of hundreds. The active VSG is expressed in a strictly mutually exclusive fashion from an expression site located at the end of a chromosome (Figure 1B). Batram et al. forced the trypanosome to express a different VSG from elsewhere in the genome. Surprisingly, a repressive gradient that extends from the chromosome end resulted in the active VSG expression site shutting down. This silencing was dependent on a histone methyltransferase (Figueiredo et al., 2008), indicating that chromatin remodelling was involved. Amazingly, this expression site silencing also appeared to trigger trypanosomes to change from the proliferative form that undergoes continuous division in the bloodstream to become the non-proliferative form that is adapted for life in the insect.

The VSG expression sites also contain expression site associated genes (ESAGs; Hertz-Fowler et al., 2008). Using genetic techniques to knock down these genes also triggered the trypanosome to change from the proliferative to the non-proliferative form. It therefore appears that some expression site associated genes could function as ‘sensors’ that cue trypanosomes to become quiescent when the expression site shuts down. This suggests that VSG expression site silencing—which could potentially be reversed—may be involved in trypanosomes preparing for life in the tsetse fly.

This reveals an interesting and unexpected connection between the silencing of the active VSG expression site and the escape of trypanosomes out of the infected host. As silencing the active expression site is reversible, the proliferating form of the parasite may be able to adopt a ‘wait and see’ state before committing to becoming non-proliferative. This challenges the paradigm that commitment to a non-proliferative form depends on the population density of the parasites, and is an irreversible process.

However, these experiments raise more questions than they answer. It is not clear if this causative link between expression site silencing and progression through the life cycle also occurs in a natural infection. Alternatively, it could be a byproduct of forcing the trypanosome to express high levels of a second surface coat gene. How often would a trypanosome normally find itself in a situation where high levels of a second VSG are expressed, but not the associated ESAGs?

Batram et al. provide illuminating insight into how trypanosomes can silence their active VSG expression site, and show that this can proceed directionally from the chromosome end as well as from the promoter (Figure 1B). However, Batram et al. also propose an unexpected link between VSG coat switching and how the parasite progresses through its life cycle. When trypanosomes reach high densities in the mammalian host, do they follow predetermined genetic programming in the hope that they will be picked up by a tsetse fly? Or alternatively, can trypanosomes reversibly probe various options? The answers will certainly prove informative as to how this seemingly simple single-celled parasite outsmarts its more highly evolved hosts.


Article and author information

Author details

  1. Cher-Pheng Ooi

    Division of Cell and Molecular Biology, Imperial College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Gloria Rudenko

    Division of Cell and Molecular Biology, Imperial College London, London, United Kingdom
    For correspondence
    Competing interests
    The authors declare that no competing interests exist.

Publication history

  1. Version of Record published: June 3, 2014 (version 1)


© 2014, Ooi and Rudenko

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.


  • 918
    Page views
  • 42
  • 0

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Cher-Pheng Ooi
  2. Gloria Rudenko
Parasites: Do trypanosome turncoats wait before they commit?
eLife 3:e03176.

Further reading

  1. How the parasite that causes sleeping sickness keeps one step ahead of its host.

    1. Cell Biology
    Meng Zhao, Niels Banhos Dannieskiold-Samsøe ... Katrin J Svensson
    Research Article

    The secreted protein Isthmin-1 (Ism1) mitigates diabetes by increasing adipocyte and skeletal muscle glucose uptake by activating the PI3K-Akt pathway. However, while both Ism1 and insulin converge on these common targets, Ism1 has distinct cellular actions suggesting divergence in downstream intracellular signaling pathways. To understand the biological complexity of Ism1 signaling, we performed phosphoproteomic analysis after acute exposure, revealing overlapping and distinct pathways of Ism1 and insulin. We identify a 53 % overlap between Ism1 and insulin signaling and Ism1-mediated phosphoproteome-wide alterations in ~ 450 proteins that are not shared with insulin. Interestingly, we find several unknown phosphorylation sites on proteins related to protein translation, mTOR pathway and, unexpectedly, muscle function in the Ism1 signaling network. Physiologically, Ism1 ablation in mice results in altered proteostasis, including lower muscle protein levels under fed and fasted conditions, reduced amino acid incorporation into proteins, and reduced phosphorylation of the key protein synthesis effectors Akt and downstream mTORC1 targets. As metabolic disorders such as diabetes are associated with accelerated loss of skeletal muscle protein content, these studies define a non-canonical mechanism by which this anti-diabetic circulating protein controls muscle biology.